Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03456687 · ClinicalTrials.gov registry record · Phase 1
Effects of Exenatide on Motor Function and the Brain
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT03456687 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 5 participants.
The verdict
NCT03456687, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this research study is to investigate how the brain and motor behavior changes Parkinson's Disease (PD) over time in response to Exenatide. In previous clinical trials, PD patients have experienced symptomatic improvement on Exenatide and literature suggests it may help slow the progression of Parkinson's. Both will be evaluated in this study.
Interventions
- DRUG Exenatide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2018-06-05 |
| Est. Completion | 2021-08-25 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03456687
The ClinicalTrials.gov registry entry for NCT03456687 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exenatide is the first listed.
NCT03456687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03456687 about?
NCT03456687 is a clinical study titled "Effects of Exenatide on Motor Function and the Brain". The purpose of this research study is to investigate how the brain and motor behavior changes Parkinson's Disease (PD) over time in response to Exenatide. In previous clinical trials, PD patients have experienced symptomatic improvement on Exenatide and literature suggests it may help slow the progr...
What is the current status of trial NCT03456687?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2018-06-05. Estimated completion is 2021-08-25.
What interventions are being tested in trial NCT03456687?
The interventions under investigation include: Exenatide (DRUG).
Who is sponsoring clinical trial NCT03456687?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.